RxDoctor Payments Data

Brittany Butler, PA

Medical · Ferrum, VANPI 1023476207

Payments from drug & device makers

$689in general payments, 2019–2025

Across 37 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$175
  • Gilead$123
  • Novo Nordisk$91
  • Lilly USA, LLC$44
  • Exact Sciences$31
  • Dexcom, Inc.$29
  • plus $196 from 10 others

What the payments were for

  • Food & beverage$66697%
  • Education$233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$689 in reported general payments places this provider in the 55th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$1,393
Medicare patients
35
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide37$45,616
JardianceEmpagliflozin22$27,552
EliquisApixaban34$24,858
OzempicSemaglutide23$21,651
FarxigaDapagliflozin Propanediol16$20,173
Tresiba Flextouch U-200Insulin Degludec14$10,365
Spiriva HandihalerTiotropium Bromide16$8,327
SymbicortBudesonide/Formoterol Fumarate25$5,954
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,314
Albuterol Sulfate HfaAlbuterol Sulfate80$1,859
Nebivolol Hcl13$1,619
Duloxetine Hcl54$1,185
Clobetasol Propionate19$1,112
Levothyroxine Sodium82$879
Gabapentin96$831

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$44$45,61637 claims
Boehringer IngelheimJardiance$21$27,55222 claims
AstraZenecaFarxiga, Symbicort$12$26,12741 claims
PfizerEliquis$23$24,85834 claims
Novo NordiskOzempic$91$21,65123 claims
GSKAnoro Ellipta$19$5,31411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 632 medical providers in Virginia.

Other medical in Ferrum

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →